Tranche Update on Shenzhen Salubris Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on October 8, 2019.

From October 6, 2019 to December 31, 2019, the company has repurchased 3,470,987 shares, representing 0.33% for CNY 65.23 million. With this, the company has completed the repurchase of 3,470,987 shares, representing 0.33% for CNY 65.23 million under the buyback announced on October 8, 2019.